New cancer drug enters first human trials for advanced cases
Disease control
Recruiting now
This is the first study in people to test a new cancer drug called IM-1021. The main goals are to find a safe dose and see how the body processes the drug in adults with advanced solid tumors or blood cancers that have not responded to standard treatments. Researchers will also l…
Phase: PHASE1 • Sponsor: Immunome, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:27 UTC